Oak Associates LTD Novo Nordisk A S Transaction History

Oak Associates LTD

$1.48 Billion
Q3 2024

A detailed history of Oak Associates LTD transactions in Novo Nordisk A S stock. As of the latest transaction made, Oak Associates LTD holds 9,283 shares of NVO stock, worth $811,055. This represents 0.07% of its overall portfolio holdings.

Number of Shares

9,283

Holding current value

$811,055

% of portfolio

0.07%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$119.07 - $145.42 $1.11 Million - $1.35 Million	9,283 New	9,283 $1.11 Million
Q1 2021 May 13, 2021	SELL	$67.06 - $75.82 $1.94 Million - $2.2 Million	-28,965 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$63.89 - $73.8 $223,295 - $257,931	-3,495 Reduced 10.77%	28,965 $2.02 Million
Q2 2020 Aug 11, 2020	SELL	$58.54 - $67.94 $1.1 Million - $1.28 Million	-18,780 Reduced 36.65%	32,460 $2.13 Million
Q2 2019 Aug 09, 2019	BUY	$46.79 - $52.47 $732,497 - $821,417	15,655 Added 43.99%	51,240 $2.62 Million
Q1 2019 May 09, 2019	BUY	$46.36 - $52.63 $639,999 - $726,557	13,805 Added 63.38%	35,585 $1.86 Million
Q4 2018 Feb 07, 2019	BUY	$41.54 - $47.25 $62,310 - $70,875	1,500 Added 7.4%	21,780 $1 Million
Q2 2018 Aug 14, 2018	SELL	$44.29 - $50.42 $9,743 - $11,092	-220 Reduced 1.07%	20,280 $935,000
Q4 2017 Feb 08, 2018	BUY	$47.53 - $53.73 $974,365 - $1.1 Million	20,500	20,500 $1.1 Million

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

Jennison Associates LLC

20.2M
Shares

$1.76 Billion
1.5% of portfolio
Morgan Stanley New York, NY

14.4M
Shares

$1.26 Billion
0.13% of portfolio
Bank Of America Corp Charlotte, NC

14.3M
Shares

$1.25 Billion
0.14% of portfolio
Ken Fisher Fisher Asset Management, LLC | Camas, Wa

13.3M
Shares

$1.16 Billion
0.65% of portfolio
Fayez Sarofim & CO Houston, TX

12.2M
Shares

$1.07 Billion
3.76% of portfolio

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oak Associates LTD , based on Form 13F filings with the SEC.

News

Stay updated on Oak Associates LTD with notifications on news.

Account